METRONIDAZOLE HYDROCHLORIDE

Pre-Launch

metronidazole hydrochloride

ANDAINJECTIONINJECTABLE

Lifecycle

Pre-Launch

Data completeness

2/8 — Basic

METRONIDAZOLE HYDROCHLORIDE (metronidazole hydrochloride) by Bristol Myers Squibb is (metronidazole and tetracycline hydrochloride) and bismuth subcitrate potassium [see microbiology ()] . Approved for duodenal ulcer disease (active, history of within the past 5 years) to eradicate h.

Drug data last refreshed 1mo ago

Mechanism of Action

(metronidazole and tetracycline hydrochloride) and bismuth subcitrate potassium [see Microbiology ()] .

Indications (2)

duodenal ulcer disease (active history of within the past 5 years) to eradicate H

Worked on METRONIDAZOLE HYDROCHLORIDE at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.